XLV was created on 1998-12-16 by SPDR. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 39667.56m in AUM and 63 holdings. XLV tracks health care stocks from within the S&P 500 Index", weighted by market cap.
Current Value
$144.331 Year Return
Current Value
$144.331 Year Return
Assets Under Management
$38.54B
Div Yield %
1.57%
P/E Ratio
28.71
Net Asset Value
$144.07
Expense Ratio
0.09%
1Y ETF Return
0.12%
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TMO | 63.68% | $197.41B | +5.86% | 0.30% |
DHR | 56.45% | $169.77B | +6.21% | 0.45% |
QGEN | 55.03% | $9.39B | +1.01% | 0.00% |
AMGN | 54.83% | $155.83B | +9.57% | 3.11% |
REGN | 53.94% | $81.81B | -6.91% | 0.00% |
IDXX | 51.03% | $34.27B | -12.50% | 0.00% |
ABT | 50.84% | $203.38B | +14.18% | 1.87% |
SYK | 50.48% | $148.73B | +32.68% | 0.82% |
BIO | 50.34% | $9.12B | +5.07% | 0.00% |
MMC | 49.18% | $110.22B | +12.11% | 1.35% |
KO | 49.16% | $274.67B | +9.14% | 2.99% |
MDT | 49.09% | $108.68B | +8.13% | 3.29% |
ELV | 48.86% | $93.60B | -15.91% | 1.58% |
ABBV | 48.69% | $303.47B | +24.02% | 3.56% |
LLY | 48.52% | $711.91B | +26.02% | 0.68% |
VRTX | 48.39% | $115.98B | +27.50% | 0.00% |
BDX | 47.78% | $65.16B | -4.79% | 1.69% |
ZBH | 47.70% | $21.58B | -4.77% | 0.88% |
LH | 47.69% | $20.09B | +13.50% | 0.90% |
BIIB | 47.61% | $23.03B | -31.67% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BNED | 0.10% | $270.40M | -91.94% | 0.00% |
XBIT | -0.14% | $201.80M | +84.92% | 0.00% |
BVN | 0.22% | $3.12B | +34.06% | 0.00% |
CBOE | -0.22% | $22.09B | +17.17% | 1.08% |
BCAN | -0.39% | $72.74M | -99.75% | 0.00% |
FLXS | 0.39% | $307.33M | +241.89% | 1.06% |
STG | -0.43% | $35.47M | +5.43% | 0.00% |
DMLP | 0.44% | $1.59B | +16.93% | 10.34% |
ASPS | -0.59% | $20.33M | -82.43% | 0.00% |
XOS | 0.74% | $32.60M | -58.61% | 0.00% |
NTIC | 0.77% | $134.44M | +28.17% | 1.97% |
VERX | 0.80% | $8.33B | +97.20% | 0.00% |
ALAB | 0.84% | $16.51B | +189.22% | 0.00% |
RDDT | -0.90% | $27.74B | +364.76% | 0.00% |
AMED | 1.08% | $2.95B | -3.97% | 0.00% |
OKLO | 1.16% | $3.08B | +143.89% | 0.00% |
PRT | 1.18% | $48.51M | -17.78% | 10.36% |
ARQ | -1.35% | $318.18M | +179.34% | 0.00% |
NAT | 1.37% | $624.30M | -32.35% | 14.12% |
POAI | 1.38% | $4.59M | -76.64% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HUSA | -34.97% | $18.58M | -19.77% | 0.00% |
BTCT | -12.17% | $58.86M | +395.83% | 0.00% |
QTTB | -11.04% | $329.37M | +172.64% | 0.00% |
PULM | -10.28% | $22.32M | +230.27% | 0.00% |
MNR | -6.41% | $1.70B | -6.89% | 15.55% |
LTM | -5.36% | $8.37B | -100.00% | <0.01% |
TCTM | -5.33% | $7.57M | -41.30% | 0.00% |
TPST | -4.28% | $39.00M | -78.67% | 0.00% |
CORZ | -3.36% | $4.90B | +3,634.04% | 0.00% |
VIRT | -3.15% | $3.25B | +113.85% | 2.55% |
UUU | -2.76% | $4.98M | -18.37% | 0.00% |
SAVA | -2.32% | $1.55B | +51.22% | 0.00% |
SCKT | -2.32% | $11.26M | +14.73% | 0.00% |
EDR | -2.10% | $9.11B | +20.37% | 0.81% |
INSM | -2.09% | $13.20B | +211.04% | 0.00% |
HIHO | -1.71% | $8.50M | -1.53% | 6.22% |
LPTH | -1.66% | $59.50M | +22.95% | 0.00% |
FATBB | -1.51% | $75.27M | -12.35% | 12.73% |
ARQ | -1.35% | $318.18M | +179.34% | 0.00% |
RDDT | -0.90% | $27.74B | +364.76% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IYH | 99.22% | $3.20B | 0.39% |
VHT | 98.61% | $17.20B | 0.1% |
FHLC | 98.43% | $2.75B | 0.084% |
IXJ | 96.88% | $3.88B | 0.41% |
RSPH | 87.28% | $879.32M | 0.4% |
FXH | 85.41% | $1.16B | 0.62% |
PPH | 84.15% | $606.64M | 0.36% |
IHE | 81.81% | $596.24M | 0.39% |
USMV | 76.28% | $23.75B | 0.15% |
BBH | 75.71% | $404.59M | 0.35% |
FTCS | 73.75% | $8.96B | 0.54% |
IBB | 73.66% | $6.64B | 0.45% |
PINK | 73.65% | $163.05M | 0.5% |
DGRO | 71.60% | $30.36B | 0.08% |
ACWV | 71.54% | $4.26B | 0.2% |
SPYV | 71.09% | $24.91B | 0.04% |
IHF | 71.07% | $709.92M | 0.4% |
FDLO | 70.97% | $1.28B | 0.15% |
TDVG | 70.78% | $843.96M | 0.5% |
IVE | 70.60% | $36.09B | 0.18% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CLOI | 0.02% | $720.91M | 0.4% |
BCI | 0.24% | $1.20B | 0.26% |
BCD | -0.27% | $245.10M | 0.3% |
IVOL | 0.36% | $549.88M | 1.02% |
FTGC | -0.55% | $2.21B | 1.02% |
GCC | 0.71% | $135.83M | 0.55% |
IBTE | -1.58% | $1.67B | 0.07% |
KRBN | -1.75% | $243.28M | 0.85% |
CMDY | 1.93% | $285.76M | 0.28% |
BILZ | 2.25% | $553.02M | 0.14% |
CORN | -2.80% | $61.32M | 0.2% |
HDRO | -2.80% | $164.26M | 0.3% |
DBB | 3.14% | $129.56M | 0.77% |
CANE | -3.56% | $17.43M | 0.29% |
JBBB | 3.94% | $1.27B | 0.49% |
USCI | -3.94% | $185.92M | 1.07% |
KCCA | -4.31% | $219.64M | 0.87% |
WEAT | -4.85% | $123.26M | 0.28% |
UNG | 5.23% | $928.64M | 1.06% |
YEAR | 5.30% | $1.14B | 0.25% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -40.64% | $195.31M | 0.85% |
TPMN | -29.43% | $40.73M | 0.65% |
TAIL | -24.79% | $68.06M | 0.59% |
USDU | -24.79% | $201.83M | 0.5% |
BTAL | -21.88% | $379.51M | 1.43% |
UUP | -18.84% | $359.07M | 0.77% |
DBE | -15.89% | $50.92M | 0.77% |
EQLS | -15.79% | $8.88M | 1% |
DBO | -15.01% | $218.38M | 0.77% |
HIGH | -13.93% | $301.36M | 0.51% |
CTA | -13.86% | $359.48M | 0.78% |
DBA | -7.88% | $768.98M | 0.93% |
KMLM | -7.87% | $348.59M | 0.9% |
PDBC | -7.69% | $4.47B | 0.59% |
COMT | -7.34% | $842.63M | 0.48% |
SOYB | -7.29% | $27.32M | 0.22% |
GSG | -7.22% | $935.59M | 0.75% |
BOXX | -6.29% | $4.43B | 0.1949% |
DBC | -6.00% | $1.41B | 0.87% |
WEAT | -4.85% | $123.26M | 0.28% |
SeekingAlpha
While it may feel like the stock market has gone gangbusters since the close on 11/5, the S&P 500 ETF is up just over 3%, while the mega-cap Tech-heavy Nasdaq 100 is up even less at 2.5%.
SeekingAlpha
Read more on the latest trends and risks in the pharmaceutical sector with insights on IHE ETF performance and healthcare sector earnings.
SeekingAlpha
Click here for analysis of HQH closed-end fund: regulatory uncertainty causing pressure, 12% managed distribution policy appeals to yield investors, heavy biotech focus.
SeekingAlpha
We advise selling healthcare stocks due to political uncertainty and unfavorable market conditions, prioritizing low-risk investments. See more on XLV ETF here.
SeekingAlpha
While the drop has resulted in extreme underperformance versus the S&P 500, it has also resulted in the sector's weight in the S&P 500 falling dramatically.
SeekingAlpha
Johnson & Johnson faces uncertainty with speculation about RFK Jr. at HHS. Learn why JNJ stock remains a buy despite political risks and soft trends.
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.